Study to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Oral
Nafithromycin Versus Oral Moxifloxacin in the Treatment of Community-Acquired Bacterial
Pneumonia (CABP) in Adults
Phase:
Phase 2
Details
Lead Sponsor:
Wockhardt
Collaborator:
ACM
Treatments:
Fluoroquinolones Moxifloxacin Nafithromycin Norgestimate, ethinyl estradiol drug combination